ALNYLAM PHARMACEUTICALS SPAIN, S.L. secures contract for Pharmaceutical products Supply of Patisiran 2 mg ml injectable perfusion 5 ml exclusive medicine marketed by Alnylam Pharmaeuticals Spain SL destined for centers dependent on the Health Service of the Balearic Islands

Spain, May 11 -- Spain based ALNYLAM PHARMACEUTICALS SPAIN, S.L. has secured contract from Servicio de Salud de las Illes Balears for Pharmaceutical products Supply of Patisiran 2 mg ml injectable perfusion 5 ml exclusive medicine marketed by Alnylam Pharmaeuticals Spain SL destined for centers dependent on the Health Service of the Balearic Islands. The value of the contract is worth 459637632 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....